Journal
INOSITOL PHOSPHOLIPID SIGNALING IN PHYSIOLOGY AND DISEASE
Volume 1280, Issue -, Pages 11-14Publisher
BLACKWELL SCIENCE PUBL
DOI: 10.1111/nyas.12091
Keywords
SHIP1; bone; osteoclast; osteoblast; PI3K; inositol phospholipid
Categories
Funding
- NIH [RO1-HL72523, R01- HL085580, R01-HL107127]
- Paige Arnold Butterfly Run
Ask authors/readers for more resources
The bone marrow milieu comprising both hematopoietic and nonhematopoietic lineages has a unique structural organization. Bone undergoes continuous remodeling throughout life. This dynamic process involves a balance between bone-forming osteoblasts (OBs) derived from multipotent mesenchymal stem cells (MSCs) and bone-resorbing osteoclasts (OCs) derived from hematopoietic stem cells (HSCs). Src homology 2-domain-containing inositol 5'-phosphatase 1 (SHIP1) regulates cellular processes such as proliferation, differentiation, and survival via the PI3K/Akt signaling pathway initiated at the plasma membrane. SHIP1-deficient mice also exhibit profound osteoporosis that has been proposed to result from hyperresorptive activity by OCs. We have previously observed that SHIP1 is expressed in primary OBs, which display defective development in SHIP1-deficient mice. These findings led us to question whether SHIP1 plays a functional role in osteolineage development from MSC in vivo, which contributes to the osteoporotic phenotype in germline SHIP1 knockout mice. In this short review, we discuss our current understanding of inositol phospholipid signaling downstream of SHIP1 in bone biology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available